Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT06786299Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
Phase 1Open Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
Founded: 2019
Portfolio: 1 clinical trial